Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2007 1
2008 2
2009 1
2010 1
2011 1
2014 1
2015 1
2016 1
2017 2
2018 1
2019 3
2020 2
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group. Galiè N, et al. Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29. Eur Heart J. 2016. PMID: 26320113 Free article. No abstract available.
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.
Maron BA, Abman SH, Elliott CG, Frantz RP, Hopper RK, Horn EM, Nicolls MR, Shlobin OA, Shah SJ, Kovacs G, Olschewski H, Rosenzweig EB. Maron BA, et al. Am J Respir Crit Care Med. 2021 Jun 15;203(12):1472-1487. doi: 10.1164/rccm.202012-4317SO. Am J Respir Crit Care Med. 2021. PMID: 33861689 Free PMC article.
The diagnosis and management of pulmonary arterial hypertension (PAH) includes several advances, such as a broader recognition of extrapulmonary vascular organ system involvement, validated point-of-care clinical assessment tools, and focus on the earl …
The diagnosis and management of pulmonary arterial hypertension (PAH) includes several advances, such as a broader reco …
Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement.
Price LC, Martinez G, Brame A, Pickworth T, Samaranayake C, Alexander D, Garfield B, Aw TC, McCabe C, Mukherjee B, Harries C, Kempny A, Gatzoulis M, Marino P, Kiely DG, Condliffe R, Howard L, Davies R, Coghlan G, Schreiber BE, Lordan J, Taboada D, Gaine S, Johnson M, Church C, Kemp SV, Wong D, Curry A, Levett D, Price S, Ledot S, Reed A, Dimopoulos K, Wort SJ. Price LC, et al. Br J Anaesth. 2021 Apr;126(4):774-790. doi: 10.1016/j.bja.2021.01.005. Epub 2021 Feb 19. Br J Anaesth. 2021. PMID: 33612249 Free article.
BACKGROUND: The risk of complications, including death, is substantially increased in patients with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures, especially in those with pulmonary arterial hyperten
BACKGROUND: The risk of complications, including death, is substantially increased in patients with pulmonary hypertension
Pulmonary arterial hypertension in children.
Widlitz A, Barst RJ. Widlitz A, et al. Eur Respir J. 2003 Jan;21(1):155-76. doi: 10.1183/09031936.03.00088302. Eur Respir J. 2003. PMID: 12570125 Free article. Review.
The natural history of pulmonary arterial hypertension is usually progressive and fatal. At the 1998 Primary Pulmonary Hypertension World Symposium, clinical scientists from around the world gathered to review and discuss the future of pulmon
The natural history of pulmonary arterial hypertension is usually progressive and fatal. At the 1998 Primary Pulmona
Interventional and surgical modalities of treatment in pulmonary hypertension.
Keogh AM, Mayer E, Benza RL, Corris P, Dartevelle PG, Frost AE, Kim NH, Lang IM, Pepke-Zaba J, Sandoval J. Keogh AM, et al. J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S67-S77. doi: 10.1016/j.jacc.2009.04.016. J Am Coll Cardiol. 2009. PMID: 19555860 Free article. Review.
Currently, there is a need for right ventricular assist devices with flow characteristics suited to the circulation of patients with pulmonary arterial hypertension. Right ventricular synchronization therapy has not yet been tested. Novel shunts (e.g., Potts …
Currently, there is a need for right ventricular assist devices with flow characteristics suited to the circulation of patients with pulm
Use of the index of pulmonary vascular disease for predicting long-term outcome of pulmonary arterial hypertension associated with congenital heart disease.
Chida-Nagai A, Masaki N, Maeda K, Sasaki K, Sato H, Muneuchi J, Ochiai Y, Murayama H, Tahara M, Shiono A, Shinozuka A, Kono F, Machida D, Toyooka S, Sugimoto S, Nakamura K, Akagi S, Kondo M, Kasahara S, Kotani Y, Koizumi J, Oda K, Harada M, Nakajima D, Murata A, Nagata H, Yatsunami K, Kobayashi T, Matsunaga Y, Inoue T, Yamagishi H, Nakagawa N, Ohtani K, Yamamoto M, Ito Y, Hokosaki T, Kuwahara Y, Masutani S, Nomura K, Wada T, Sawada H, Abiko M, Takahashi T, Ishikawa Y, Okada S, Naitoh A, Toda T, Ando T, Masuzawa A, Hoshino S, Kawada M, Nomura Y, Ueno K, Ohashi N, Tachibana T, Cao Y, Ueda H, Yanagi S, Koide M, Mitsushita N, Higashi K, Minosaki Y, Hayashi T, Okamoto T, Kuraishi K, Ehara E, Ishida H, Horigome H, Murakami T, Takei K, Ishii T, Harada G, Hirata Y, Maeda J, Tatebe S, Ota C, Hayabuchi Y, Sakazaki H, Sasaki T, Hirono K, Suzuki S, Yasuda M, Takeda A, Sawai M, Miyaji K, Kitagawa A, Nakai Y, Kakimoto N, Agematsu K, Manabe A, Saiki Y. Chida-Nagai A, et al. Front Cardiovasc Med. 2023 Sep 4;10:1212882. doi: 10.3389/fcvm.2023.1212882. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37731527 Free PMC article.
AIMS: Limited data exist on risk factors for the long-term outcome of pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD-PAH). We focused on the index of pulmonary vascular disease (IPVD), an assessment sy …
AIMS: Limited data exist on risk factors for the long-term outcome of pulmonary arterial hypertension (PAH) asso …
Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension.
Toyoda Y, Thacker J, Santos R, Nguyen D, Bhama J, Bermudez C, Kormos R, Johnson B, Crespo M, Pilewski J, Teuteberg J, Alvarez R, Mathier M, McNamara D, McCurry K, Zenati M, Hattler B. Toyoda Y, et al. Ann Thorac Surg. 2008 Oct;86(4):1116-22. doi: 10.1016/j.athoracsur.2008.05.049. Ann Thorac Surg. 2008. PMID: 18805144
BACKGROUND: The survival after lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension has been reportedly the lowest among the major diagnostic categories of lung transplant recipients. METHODS: Retrospective a …
BACKGROUND: The survival after lung and heart-lung transplantation for idiopathic pulmonary arterial hyperten
Congenital heart disease associated pulmonary arterial hypertension.
Landzberg MJ. Landzberg MJ. Clin Chest Med. 2007 Mar;28(1):243-53, x. doi: 10.1016/j.ccm.2006.12.004. Clin Chest Med. 2007. PMID: 17338939 Review.
Pulmonary arterial hypertension associated with congenital heart disease, although common (15%-30%) in all-comers with congenital heart disease, is variable in terms of clinical manifestations, severity of associated pulmonary arterial hypert
Pulmonary arterial hypertension associated with congenital heart disease, although common (15%-30%) in all-comers with
Safety and Feasibility of Performing Pericardiocentesis on Patients with Significant Pulmonary Hypertension.
Case BC, Yang M, Kagan CM, Yerasi C, Forrestal BJ, Tariq MU, Medvedofsky D, Hashim H, Rogers T, Satler LF, Waksman R, Ben-Dor I. Case BC, et al. Cardiovasc Revasc Med. 2019 Dec;20(12):1090-1095. doi: 10.1016/j.carrev.2019.09.022. Epub 2019 Oct 22. Cardiovasc Revasc Med. 2019. PMID: 31870527
BACKGROUND/PURPOSE: Pericardial effusion (PE) is a complication of pulmonary hypertension (PHT) and, specifically, pulmonary arterial hypertension (PAH), that confers a worse prognosis. ...However, the safety of performing pericardiocentesis in …
BACKGROUND/PURPOSE: Pericardial effusion (PE) is a complication of pulmonary hypertension (PHT) and, specifically, pulmonar
Right ventricular function during and after thoracic surgery.
Gelzinis T, Assaad S, Perrino AC Jr. Gelzinis T, et al. Curr Opin Anaesthesiol. 2020 Feb;33(1):27-36. doi: 10.1097/ACO.0000000000000809. Curr Opin Anaesthesiol. 2020. PMID: 31724957
Acute RV dysfunction can present intraoperatively and postoperatively, persisting for 2 months after surgery. RECENT FINDINGS: Recently, the pulmonology literature has emphasized pulmonary arterial capacitance, rather than pulmonary vascular resistance …
Acute RV dysfunction can present intraoperatively and postoperatively, persisting for 2 months after surgery. RECENT FINDINGS: Recent …
20 results